Business Wire

RTA Unveils Finalists of Dubai World Challenge for Self-Driving Transport

Jaa

HE Mattar Al Tayer, Director-General and Chairman of the Board of Executive Directors of Dubai Roads and Transport Authority (RTA), announced that the participation in the Dubai World Challenge for Self-Driving Transport had exceeded the target by 30%, by the end of registration phase. Al Tayer made this statement during a press conference held to announce the finalists of the Challenge.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181028005023/en/

Al Tayer with Dr. Arif and Laila Faridoon (Photo: AETOSWire)

Al Tayer with Dr. Arif and Laila Faridoon (Photo: AETOSWire)

Companies, universities, colleges and institutions submitted applications globally. Attendees of the event included Dr. Arif Al Hammadi Executive Vice President of Khalifa University, Ms. Laila Faridoon, Chairperson of the Organising Committee of the Dubai World Congress for Self-Driving Transport; Dr. Steve Shladover, the International Jury Head of Dubai World Challenge for Self-Driving Transport; and Adel Shakri, Head of the Dubai World Challenge for Self-Driving Transport Committee.

The Leaders Category finalists included: Navya and EasyMile from France, Drive.ai from the USA, Westfield from the UK, Baidu from China, and 2getthere from the Netherland.

The list of start-ups finalists included: Sensible from Finland, Derq from the UAE, and IAuto from Taiwan.

As for the local universities, announced finalists were: Dubai University, UAE University, Al Ain University of Science and Technology, and Abu Dhabi University. Amongst the international universities, Friee Berlin University in Germany, CMU in the US, Intelligent Systems Lab at Universidad Carlos lll de Madrid in Spain, and UTS in Australia represent the finalists of this category.

“The Challenge award amounts to more than US$5 million; US$3 million will be allocated to leader’s category, US$1.5m to start-ups category, and US$600,000 to local and foreign universities (US$300,000 each). A team of international experts in the field of smart mobility will assess the finalists by several technical criteria,” said Al Tayer.

“The challenge encourages the participants to cope with the existing challenges of the First /Last Mile, traffic congestions and the drop in the public transport ridership. Driverless transport has become a key pillar of RTA’s strategy, and we are making every endeavour to make it a reality in Dubai,” he added.

Finalists will be subjected to intensive tests in Dubai in 2019, and an international jury panel will review all submissions to select the winners of the inaugural edition of the Challenge. Winners will be honoured during the first edition of the Dubai World Conference for Self-Driving Transport scheduled to be held in October 2019.

Al Tayer also praised the Dubai World Challenge for Self-Driving Transport partners: Telecommunications Regulatory Authority, Union Properties, Meraas, Dubai Silicon Oasis and Dubai Future Foundation

Challenge Standards

The Finalists were assessed by several parameters including: The credibility, vision, skills and relevant experiences of the entity. Nominees will then be judged in their respective categories according to their performance in tests conducted as per the following standards:

  • Technical ability and experience: Vehicle manufacturing, flexibility, battery technology, and the command & control system
  • Business aspect: Operability, added value, and relevance to the needs of Dubai and the UAE.
  • Operation and service: Innovative solutions, operation method, the ability to run services and working hours.

The Challenge encompasses a series of tests related to:

  • Durability and reliability
  • Ability to drive under traffic conditions simulating the reality
  • Power efficiency and environmental compatibility
  • Electronic safety and security
  • User’s experience

*Source: AETOSWire

Contact information

Roads and Transport Authority (RTA)
Maryam Al Balooshi, +97142902699
Manager, Media Communication
Marketing and Corporate Communication Department
Maryam.HAlblooshi@rta.ae

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Pioneering Project for Pharmaceutics – Vifor Pharma and the University of Basel are Jointly Establishing the World’s First Research Professorship for Nanopharmaceutical and Regulatory Science26.5.2019 10:00:00 EESTTiedote

Nanopharmaceutics promises ground-breaking innovation in the development of medicines: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190526005014/en/ The Vifor Pharma Group is endowing two professorships for Nanopharmaceutical and Regulatory Science at the University of Basel The commitment by Vifor Pharma and the University of Basel is aimed at ensuring Switzerland has the specialist knowledge and equipment needed to compete globally in this important emerging area of life sciences With this decision, Vifor Pharma is demonstrating its commitment to Switzerland as a world-leading location for pharmaceutical research and development Nanomedicines are playing an increasingly important role in the development of innovative new medications. These drugs are able to overcome specific cellular barriers in the human body with a view to targeting their effect even more precisely. Nanopharmacy therefore promises to help advance medic

XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 21:20:00 EESTTiedote

On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 17:00:00 EESTTiedote

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 13:20:00 EESTTiedote

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 08:00:00 EESTTiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 04:00:00 EESTTiedote

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme